FRAXA Research Foundation – Fellowship Proposals

Ends on 2 February 2026

FRAXA ‘s mission is to find specific treatments and ultimately a cure for Fragile X syndrome. We aim to bring practical treatment into current medical practice as quickly as possible; we prioritize projects that have a clear practical application and the results of which will be shared in a timely fashion.

FRAXA awards the following types of funding:

1. Clinical Trial applications are accepted and reviewed on a revolving basis; there is no application deadline.
2. Curative Therapies proposals are accepted and reviewed at any time.
3. FRAXA Fellowship applications are due on February 1 each year.

More details